Acute and chronic neutral endopeptidase inhibition and the natriuretic response to acute volume expansion.

[1]  R. Lafayette,et al.  Anaritide in Acute Tubular Necrosis , 1997 .

[2]  G. Fuiano,et al.  Pathophysiological role and diuretic efficacy of atrial natriuretic peptide in renal patients. , 1997, Journal of the American Society of Nephrology : JASN.

[3]  R. Dietz,et al.  Acute and chronic neutral endopeptidase inhibition in rats with aortocaval shunt. , 1996, Hypertension.

[4]  E. Fleck,et al.  Regulation and differential expression of neutral endopeptidase 24.11 in human endothelial cells. , 1995, Hypertension.

[5]  M. Burnier,et al.  Neutral endopeptidase versus angiotensin converting enzyme inhibition in essential hypertension , 1995, Journal of hypertension.

[6]  J. Stasch,et al.  Prolonged inhibition of neutral endopeptidase 24.11 by sinorphan in stroke-prone spontaneously hypertensive rats. , 1995, Hypertension research : official journal of the Japanese Society of Hypertension.

[7]  F. Pieruzzi,et al.  Pulmonary and renal neutral endopeptidase EC 3.4.24.11 in rats with experimental heart failure. , 1995, Hypertension.

[8]  R. Mayfield,et al.  Rat renal interstitial bradykinin, prostaglandin E2, and cyclic guanosine 3',5'-monophosphate. Effects of altered sodium intake. , 1994, Hypertension.

[9]  K. Shimamoto,et al.  The role of kinins and atrial natriuretic peptide on the renal effects of neutral endopeptidase inhibitor in rats. , 1994, Clinical and experimental hypertension.

[10]  J. Scott,et al.  Renal effects of neutral endopeptidase inhibition in euvolemic and hypervolemic rats. , 1993, European journal of pharmacology.

[11]  G. Wittert,et al.  Chronic inhibition of endopeptidase 24.11 in essential hypertension: evidence for enhanced atrial natriuretic peptide and angiotensin II , 1993, Journal of hypertension.

[12]  I. Ichikawa,et al.  Biological significance of atrial natriuretic peptide in the kidney. , 1993, Nephron.

[13]  D. Goeddel,et al.  Molecular Biology of the Natriuretic Peptides and Their Receptors , 1992, Circulation.

[14]  E. Ongini,et al.  The Neutral Endopeptidase Inhibitor, SCH 34826, Reduces Left Ventricular Hypertrophy in Spontaneously Hypertensive Rats , 1992, Journal of cardiovascular pharmacology.

[15]  D. de Zeeuw,et al.  Atrial natriuretic factor: its (patho)physiological significance in humans. , 1992, Kidney international.

[16]  N. Markandu,et al.  Is atrial natriuretic peptide-guanosine 3',5' cyclic monophosphate coupling a determinant of urinary sodium excretion in essential hypertension? , 1992, Journal of hypertension.

[17]  O. Vuolteenaho,et al.  Basal and volume expansion-stimulated plasma atrial natriuretic peptide concentrations and hemodynamics in conscious rats: effects of SCH 39.370, an endopeptidase inhibitor, and C-ANF-(4-23), a clearance receptor ligand. , 1992, Endocrinology.

[18]  K. Margulies,et al.  Angiotensin inhibition potentiates the renal responses to neutral endopeptidase inhibition in dogs with congestive heart failure. , 1991, The Journal of clinical investigation.

[19]  G. Wittert,et al.  Prolonged inhibition of endopeptidase 24.11 in normal man: renal, endocrine and haemodynamic effects. , 1991, Journal of hypertension.

[20]  N. Trippodo,et al.  Heart Failure Augments the Cardiovascular and Renal Effects of Neutral Endopeptidase Inhibition in Rats , 1991, Journal of cardiovascular pharmacology.

[21]  M. Burnier,et al.  Effects of SCH 34826, an orally active inhibitor of atrial natriuretic peptide degradation, in healthy volunteers , 1991, Clinical pharmacology and therapeutics.

[22]  I. Tikkanen,et al.  Prolonged neutral endopeptidase inhibition in heart failure. , 1991, European journal of pharmacology.

[23]  K. Margulies,et al.  ANF-mediated renal cGMP generation in congestive heart failure. , 1991, The American journal of physiology.

[24]  J. Hunt,et al.  Possible regulation of atrial natriuretic factor by neutral endopeptidase 24.11 and clearance receptors. , 1991, The Journal of pharmacology and experimental therapeutics.

[25]  K. Margulies,et al.  Cardiorenal actions of neutral endopeptidase inhibition in experimental congestive heart failure. , 1990, Circulation.

[26]  P. Hamet,et al.  Atrial natriuretic peptide--cyclic GMP coupling and urinary sodium excretion during acute volume expansion in man. , 1990, Canadian journal of physiology and pharmacology.

[27]  P. Chiu,et al.  Atrial Natriuretic Factor‐Potentiating and Antihypertensive Activity of SCH 34826: An Orally Active Neutral Metalloendopeptidase Inhibitor , 1990, Hypertension.

[28]  G. Dibona,et al.  Renal and hemodynamic effects of atrial natriuretic peptide in patients with cirrhosis. , 1990, The American journal of the medical sciences.

[29]  K. James,et al.  UK-69,578, a novel inhibitor of EC 3.4.24.11 which increases endogenous ANF levels and is natriuretic and diuretic. , 1989, Biochemical and biophysical research communications.

[30]  E. H. Blaine,et al.  Interaction of non-guanylate cyclase-linked atriopeptin receptor ligand and endopeptidase inhibitor in conscious rats. , 1989, The Journal of pharmacology and experimental therapeutics.

[31]  T. Inagami,et al.  Atrial natriuretic factor. , 1989, The Journal of biological chemistry.

[32]  R. Skidgel,et al.  Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones 1 , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[33]  R. Ogilvie,et al.  Cardiac and vascular effects of atrial natriuretic factor and sodium nitroprusside in healthy men. , 1989, Circulation.

[34]  M. Wilkins,et al.  Urinary guanosine 3':5'-cyclic monophosphate but not tissue kallikrein follows the plasma atrial natriuretic factor response to acute volume expansion with saline. , 1988, Clinical science.

[35]  J. Lewicki,et al.  Physiological role of silent receptors of atrial natriuretic factor. , 1987, Science.

[36]  M. Cantin,et al.  Role of right and left atria in natriuresis and atrial natriuretic factor release during blood volume changes in the conscious rat. , 1987, Circulation research.

[37]  Y. Kabayama,et al.  Stimulation by volume expansion of atrial natriuretic peptide release from perfused rat heart , 1987, Peptides.

[38]  M. Cantin,et al.  Atrial natriuretic factor in human plasma. , 1986, Biochemical and biophysical research communications.

[39]  E. Schiffrin,et al.  Cyclic GMP as mediator and biological marker of atrial natriuretic factor. , 1986, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[40]  F. Murad,et al.  Atrial natriuretic factor selectively activates particulate guanylate cyclase and elevates cyclic GMP in rat tissues. , 1984, The Journal of biological chemistry.

[41]  M. Cantin,et al.  Effect of native and synthetic atrial natriuretic factor on cyclic GMP. , 1984, Biochemical and biophysical research communications.

[42]  P. Hamet,et al.  Preparation of cyclic nucleotide antisera with thyroglobulin-cyclic nucleotide conjugates. , 1980, Journal of cyclic nucleotide research.